Kebotix Announces Investment by SIT Capital

Mar 24, 2021•over 4 years ago

Cambridge

Description

Kebotix, a Cambridge-based technology platform company for new chemicals and materials, announced SIT Capital as a major investor in its Series A funding. The $11.4 million round, announced last spring, was led by Denmark-based Novo Holdings, a leading international life science investor.

Company Information

Company

Kebotix

Location

Cambridge, Maryland, United States

About

Kebotix partners with the private and public sector in harnessing the power of its breakthrough platform that combines artificial intelligence and robotic automation to discover chemicals and materials significantly faster and more affordably. Kebotix is backed by a growing, talented and dedicated team led by world-class scientists and serial entrepreneurs – plus the world’s first self-driving lab for materials discovery – to develop AI/machine learning roadmaps and define problems and solution properties for its partners, and solve the world’s most urgent problems for everyone else. Kebotix provides its partners technology access to its digital R&D solutions and complete end-to-end materials innovation programs to stay ahead of competition in the digital revolution. For more information, visit www.kebotix.com.